Low hepatic cytochrome P450 3A activity is a risk for corticosteroid-induced osteonecrosis

被引：8
|
作者：
Nafziger, A. N. [1 ]
Bertino, J. S., Jr. [1 ]
机构：
[1] Ordway Res Inst, Inst Drug Dev Ctr, Albany, NY USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2007年 / 82卷 / 04期
关键词：
D O I：
10.1038/sj.clpt.6100105
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：379 / 379
页数：1
相关论文
共 50 条
  • [31] Differentiation of intestinal and hepatic cytochrome P450 3A activity with use of midazolam as an in vivo probe: Effect of ketoconazole
    Tsunoda, SM
    Velez, RL
    von Moltke, LL
    Greenblatt, DJ
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 66 (05) : 461 - 471
  • [32] Cytochrome P450 3A, NADPH cytochrome P450 reductase and cytochrome b5 in the upper airways in horse
    Tyden, E.
    Olsen, L.
    Tallkvist, J.
    Tjalve, H.
    Larsson, P.
    RESEARCH IN VETERINARY SCIENCE, 2008, 85 (01) : 80 - 85
  • [33] Induction of hepatic cytochrome P450 2B and P450 3A isozymes in rats by zolazepam, a constituent of Telazol(R)
    Wong, A
    Bandiera, SM
    BIOCHEMICAL PHARMACOLOGY, 1998, 55 (02) : 201 - 207
  • [34] Association between nonalcoholic hepatic steatosis and hepatic cytochrome P-450 3A activity
    Kolwankar, Dhanashri
    Vuppalanchi, Raj
    Ethell, Brian
    Jones, David R.
    Wrightow, Steven A.
    Hall, Stephen D.
    Chalasani, Naga
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2007, 5 (03) : 388 - 393
  • [35] The Structure-Activity Correlation on the Inhibitory Effects of Flavonoids on Cytochrome P450 3A Activity
    Tsujimoto, Masayuki
    Horie, Maya
    Honda, Hiroko
    Takara, Kohji
    Nishiguchi, Kohshi
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2009, 32 (04) : 671 - 676
  • [36] Inactivation of the hepatic cytochrome P450 system by conditional deletion of hepatic cytochrome P450 reductase
    Henderson, CJ
    Otto, DME
    Carrie, D
    Magnuson, MA
    McLaren, AW
    Rosewell, I
    Wolf, CR
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (15) : 13480 - 13486
  • [37] Interaction of cytochrome P450 3A inhibitors with P-glycoprotein
    Yasuda, K
    Lan, LB
    Sanglard, D
    Furuya, K
    Schuetz, JD
    Schuetz, EG
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 303 (01): : 323 - 332
  • [38] Cloning, expression, and characterization of cytochrome P450 3A in minipig
    Soucek, P
    Anzenbacher, P
    Zuber, R
    Anzenbacherová, E
    Guengerich, FP
    TOXICOLOGY, 2001, 164 (1-3) : 146 - 146
  • [39] Metabolism of Beclomethasone Dipropionate by Cytochrome P450 3A Enzymes
    Roberts, Jessica K.
    Moore, Chad D.
    Ward, Robert M.
    Yost, Garold S.
    Reilly, Christopher A.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2013, 345 (02): : 308 - 316
  • [40] Cytochrome P450 3A polymorphisms and immunosuppressive drugs:: an update
    Anglicheau, Dany
    Legendre, Christophe
    Beaune, Philippe
    Thervet, Eric
    PHARMACOGENOMICS, 2007, 8 (07) : 835 - 849
12345